International Conference on Medicinal Chemistry and Admet Studies (ICMCADMET - 26)

This track will explore recent breakthroughs in medicinal chemistry, focusing on novel compounds and their therapeutic potentials. Emphasis will be placed on innovative methodologies that enhance drug efficacy and safety.

This session will delve into the importance of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies in the drug development process. Participants will discuss strategies to optimize these parameters for improved drug candidates.

This track will address the complexities of pharmacokinetics and its role in drug metabolism. Presentations will cover modeling approaches and experimental techniques to predict drug behavior in biological systems.

This session will focus on cutting-edge drug design methodologies, including structure-based and ligand-based approaches. Attendees will gain insights into the integration of computational tools in the drug design process.

This track will highlight the application of molecular modeling and simulation in understanding drug interactions at the molecular level. Discussions will include advancements in software and algorithms that enhance predictive accuracy.

This session will emphasize the role of translational research in bridging the gap between laboratory discoveries and clinical applications. Case studies will illustrate successful transitions from bench to bedside.

This track will cover various laboratory techniques employed in the drug discovery process, including high-throughput screening and in vitro assays. Participants will share best practices and innovations in experimental methodologies.

This session will explore the intersection of chemical biology and medicinal chemistry, focusing on the mechanisms of action of therapeutic agents. Presentations will discuss how chemical tools can elucidate biological pathways.

This track will investigate the latest trends in computational chemistry and their implications for medicinal chemistry. Topics will include machine learning applications and the use of artificial intelligence in drug discovery.

This session will highlight the significance of natural products as sources of novel therapeutic agents. Discussions will focus on isolation, characterization, and optimization of bioactive compounds from natural sources.

This track will address the regulatory landscape surrounding drug development, including guidelines for safety and efficacy assessments. Participants will discuss the challenges and strategies for meeting regulatory requirements.